Related Experiment Video
Updated: Sep 8, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Systematic lncRNA mapping to genome-wide co-essential modules uncovers cancer dependency on uncharacterized lncRNAs
Ramkrishna Mitra1, Clare M Adams1, Christine M Eischen1
1Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, United States.
Abstract:
Quantification of gene dependency across hundreds of cell lines using genome-scale CRISPR screens has revealed co-essential pathways/modules and critical functions of uncharacterized genes. In contrast to protein-coding genes, robust CRISPR-based loss-of-function screens are lacking for long noncoding RNAs (lncRNAs), which are key regulators of many cellular processes, leaving many essential lncRNAs unidentified and uninvestigated. Integrating copy number, epigenetic, and transcriptomic data of >800 cancer cell lines with CRISPR-derived co-essential pathways, our method recapitulates known essential lncRNAs and predicts proliferation/growth dependency of 289 poorly characterized lncRNAs. Analyzing lncRNA dependencies across 10 cancer types and their expression alteration by diverse growth inhibitors across cell types, we prioritize 30 high-confidence pan-cancer proliferation/growth-regulating lncRNAs. Further evaluating two previously uncharacterized top proliferation-suppressive lncRNAs (PSLR-1, PSLR-2) showed they are transcriptionally regulated by p53, induced by multiple cancer treatments, and significantly correlate to increased cancer patient survival. These lncRNAs modulate G2 cell cycle-regulating genes within the FOXM1 transcriptional network, inducing a G2 arrest and inhibiting proliferation and colony formation. Collectively, our results serve as a powerful resource for exploring lncRNA-mediated regulation of cellular fitness in cancer, circumventing current limitations in lncRNA research.
Insights
Researchers identified essential long noncoding RNAs (lncRNAs) regulating cancer cell proliferation using CRISPR screens and multi-omics data. Two novel lncRNAs, PSLR-1 and PSLR-2, were found to suppress tumor growth by arresting the cell cycle.
Area of Science:
- Genomics
- Cancer Biology
- RNA Biology
Background:
- Genome-scale CRISPR screens identify essential genes in cancer cell lines.
- Long noncoding RNAs (lncRNAs) are crucial regulators, but their essentiality is understudied due to limited loss-of-function screening methods.
- Uncharacterized lncRNAs play significant roles in cellular processes, yet many remain undiscovered.
Purpose of the Study:
- To develop a method for identifying essential lncRNAs using integrated genomic and transcriptomic data.
- To discover novel lncRNAs that regulate cancer cell proliferation and growth.
- To prioritize lncRNAs with potential as pan-cancer therapeutic targets.
Main Methods:
- Integrated analysis of copy number, epigenetic, and transcriptomic data from over 800 cancer cell lines.
- Utilized CRISPR-derived co-essential pathway information to predict lncRNA dependencies.
- Prioritized lncRNAs based on dependency across cancer types and response to growth inhibitors.
Main Results:
- Successfully recapitulated known essential lncRNAs and predicted 289 poorly characterized lncRNAs involved in proliferation.
- Identified 30 high-confidence lncRNAs regulating proliferation across multiple cancer types.
- Characterized two novel proliferation-suppressive lncRNAs (PSLR-1, PSLR-2) regulated by p53 and linked to patient survival.
Conclusions:
- The study provides a powerful resource for lncRNA discovery in cancer, overcoming current screening limitations.
- PSLR-1 and PSLR-2 modulate the FOXM1 network to induce G2 cell cycle arrest, inhibiting cancer proliferation.
- These findings highlight the potential of lncRNAs as therapeutic targets in oncology.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancers Originate from Somatic Mutations in a Single Cell
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
MicroRNAs

